Sotera Health Company

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sotera Health Company (“Sotera” or “the Company”) (NASDAQ: SHC) for violations of the securities laws.

-->

bluebird bio, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Seeking Alpha reports that bluebird “announced with its Q4 2023 results that the company will have to restate its financials for 2022 and 2023 after finding several accounting errors.” The report added that the Company “said the errors relate to the recognition of certain leasing arrangements with contract manufacturers.” Based on this news, shares of bluebird fell by more than 13% in intraday trading on the same day.

-->

Apple Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Apple is the subject of an Investor’s Business Daily report published on March 21, 2024, titled: “Apple Stock Drops As Justice Department Sues iPhone Maker.” According to the report, “The lawsuit alleges that Apple’s conduct makes it harder for Americans to switch smartphones, undermines innovation for apps, and imposes extraordinary costs on developers, businesses and consumers.” Based on this news, shares of Apple dropped by 4.29% in intraday trading on the same day.

-->

Equinix, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Equinix is the subject of a report released by Hindenburg Research on March 20, 2024, titled: “Equinix Exposed: Major Accounting Manipulation, Core Business Decay And Selling an AI Pipe Dream As Insiders Cashed Out Hundreds of Millions.” According to the report Hindenburg’s “investigation, which included a review of financial and litigation records and interviews with 37 former Equinix employees, industry experts and competitors, revealed that Equinix manipulates its accounting for AFFO (“adjusted funds from operations”), the key profitability metric for REITs. We estimate this metric was overstated by at least 22% in 2023 alone.”

-->

Inari Medical, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Inari filed an Annual Report on Form 10-K on February 28, 2024, stating, “on December 2023, we received a civil investigative demand (“CID”) from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the “Investigation”). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”). We are cooperating with the Investigation. We are unable to express a view at this time regarding the likely duration, or ultimate outcome, of the Investigation or estimate the possibility of, or amount or range of, any possible financial impact. Depending on the outcome of the Investigation, there may be a material impact on our business, results of operations, or financial condition.”

-->

Planet Fitness, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Planet Fitness is the subject of an article published by Benzinga on March 19, 2024, titled: “’Give Planet Fitness The Bud Light Treatment’ — Calls Grow To Boycott Gym After String Of Sexual Abuse From Men In Women’s Bathrooms.” The articles claims that, “Growing concerns and controversy surrounding Planet Fitness’s inclusive policies have sparked significant debate and calls for boycotts, reminiscent of the backlash against Bud Light for its marketing decisions.” Based on this news, shares of Planet Fitness traded down sharply across several days.

-->

Lifecore Biomedical, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Lifecore announced on March 20, 2024, that its Board of Directors had concluded its review of strategic alternatives, in which it “unanimously concluded that the best way to maximize value for stockholders at this time is to continue executing on the Company’s standalone strategic plan.” The Company also announced a leadership transition by naming a new CEO. Based on this news, shares of Lifecore fell by 35.6% in morning trading on the same day.

-->

Spruce Biosciences, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Spruce is the subject of a Seeking Alpha report published on March 13, 2024. According to the report, the Company’s “stock plunged 75% in post-market trading Tuesday on news that the company plans to cut 21% of its workforce in the wake of a failed Phase 2 study for its drug candidate tildacerfont.” The report continues, “The biotech company said the study, called CAHmelia-203, failed to meet its primary endpoint and was being terminated as a result. The study had been evaluating tildacerfont in the treatment of adult classic congenital adrenal hyperplasia, or CAH, with severe hyperandrogenemia.”

-->

Luna Innovations Incorporated

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Luna is the subject of a report by Dow Jones on March 12, 2024. According to the report, the Company “said a special committee is reviewing certain 2023 transactions and Luna expects to report material weaknesses in internal controls.” Based on this news, shares of Luna fell by more than 39% in intraday trading on March 13, 2024.

-->

Dollar Tree, Inc.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Dollar Tree is the subject of a report by Bloomberg published on March 13, 2024. According to the report, the Company “plans to shutter about 1,000 stores in an effort to improve profitability as the discount retailer battles a spate of litigation and other headwinds.” Based on this news, shares of Dollar Tree fell by more than 15% in morning trading on the same day.

-->